blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3644720

EP3644720 - NON-HUMAN MODEL FOR NEUROFIBROMATOSIS TYPE 1 [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  05.01.2024
Database last updated on 25.09.2024
FormerGrant of patent is intended
Status updated on  30.08.2023
FormerExamination is in progress
Status updated on  26.03.2021
FormerRequest for examination was made
Status updated on  03.04.2020
FormerThe international publication has been made
Status updated on  04.01.2019
Formerunknown
Status updated on  07.07.2018
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): PL
published on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Paris Sciences et Lettres
60, rue Mazarine
75006 Paris / FR
For all designated states
Centre National de la Recherche Scientifique
3, rue Michel-Ange
75016 Paris / FR
For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75654 Paris Cedex 13 / FR
[2024/06]
Former [2021/48]For all designated states
Paris Sciences et Lettres
60 Rue Mazarine
75006 Paris / FR
For all designated states
Centre National de la Recherche Scientifique
3, rue Michel-Ange
75016 Paris / FR
For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75654 Paris Cedex 13 / FR
Former [2020/19]For all designated states
Paris Sciences et Lettres - Quartier Latin
60 Rue Mazarine
75006 Paris / FR
For all designated states
Centre National de la Recherche Scientifique
3, rue Michel-Ange
75016 Paris / FR
For all designated states
INSERM (Institut National de la Santé et de la Recherche Médicale)
101, rue de Tolbiac
75654 Paris Cedex 13 / FR
Inventor(s)01 / TOPILKO, Piotr
15 rue de la Midorge
91470 Boullay-les-Troux / FR
02 / CHARNAY, Patrick
3 rue Margotin
92340 Bourg-la-Reine / FR
03 / COULPIER, Fanny
9 allée des Frères Lumière
94410 Saint-Maurice / FR
04 / GRESSET, Aurélie
99 bis rue Adolphe Pajeaud
92160 Antony / FR
05 / RADOMSKA, Katarzyna
71 rue du Faubourg Saint Antoine
75011 Paris / FR
 [2020/19]
Representative(s)Icosa
83 avenue Denfert-Rochereau
75014 Paris / FR
[2020/19]
Application number, filing date18733885.029.06.2018
[2020/19]
WO2018EP67675
Priority number, dateEP2017030582229.06.2017         Original published format: EP 17305822
[2020/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019002590
Date:03.01.2019
Language:EN
[2019/01]
Type: A1 Application with search report 
No.:EP3644720
Date:06.05.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 03.01.2019 takes the place of the publication of the European patent application.
[2020/19]
Type: B1 Patent specification 
No.:EP3644720
Date:07.02.2024
Language:EN
[2024/06]
Search report(s)International search report - published on:EP03.01.2019
ClassificationIPC:A01K67/027, C07K14/47
[2020/19]
CPC:
A01K67/0276 (EP,US); A61K49/0008 (US); C07K14/47 (EP);
C12N5/0693 (US); G01N33/5044 (US); A01K2217/054 (US);
A01K2217/206 (EP,US); A01K2227/105 (EP,US); A01K2267/0331 (EP,US);
G01N2500/10 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/19]  
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:NICHTMENSCHLICHES MODELL FÜR NEUROFIBROMATOSE TYP 1[2024/06]
English:NON-HUMAN MODEL FOR NEUROFIBROMATOSIS TYPE 1[2020/19]
French:MODÈLE NON-HUMAIN DE LA NEUROFIBROMATOSIS DE TYPE 1[2024/06]
Former [2020/19]NICHTMENSCHLICHES MODELL FÜR NEUROFIBROMATOSE TYP 1
Former [2020/19]MODÈLE NON HUMAIN POUR NEUROFIBROMATOSE TYPE 1
Entry into regional phase29.01.2020National basic fee paid 
29.01.2020Designation fee(s) paid 
29.01.2020Examination fee paid 
Examination procedure27.12.2019Amendment by applicant (claims and/or description)
29.01.2020Examination requested  [2020/19]
29.01.2020Date on which the examining division has become responsible
26.03.2021Despatch of a communication from the examining division (Time limit: M04)
15.07.2021Reply to a communication from the examining division
07.11.2022Despatch of a communication from the examining division (Time limit: M04)
07.03.2023Reply to a communication from the examining division
31.08.2023Communication of intention to grant the patent
27.12.2023Receipt of the translation of the claim(s)
02.01.2024Fee for grant paid
02.01.2024Fee for publishing/printing paid
Fees paidRenewal fee
30.06.2020Renewal fee patent year 03
30.06.2021Renewal fee patent year 04
27.06.2022Renewal fee patent year 05
27.06.2023Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipES07.02.2024
HR07.02.2024
PL07.02.2024
NO07.05.2024
RS07.05.2024
GR08.05.2024
IS07.06.2024
[2024/36]
Former [2024/35]ES07.02.2024
HR07.02.2024
NO07.05.2024
RS07.05.2024
GR08.05.2024
IS07.06.2024
Former [2024/34]HR07.02.2024
NO07.05.2024
RS07.05.2024
GR08.05.2024
IS07.06.2024
Former [2024/33]NO07.05.2024
IS07.06.2024
Former [2024/32]IS07.06.2024
Cited inInternational search[A]US2011035815  (ZONG HUI [US], et al);
 [A]WO2016077429  (RECOMBINETICS INC [US]);
by applicantUS6172188
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.